4DMedical secures funding facility with Alpha Investment Partners

4DMedical Limited (ASX: $4DX) has secured an At-the-Market (ATM) funding facility with Alpha Investment Partners (AIP) to augment the Company's capital management program. The ATM facility will provide 4DMedical with up to $30m of equity capital over the next 3 years, in addition to the Company's strong cash balance of $41.2m as of 31 March 2024.

Executive commentary on funding facility

We are building a generational business and have been setting in place the foundations for rapid, scalable growth. We have a strong cash balance, revenues are growing strongly with additional significant upside opportunities in the short and medium term, and costs are tightly under control. While the ATM is a relatively new capital management mechanism in Australia, they are widely used in the United States. With this facility in place, I am confident 4DMedical won't need to undertake any further secondary raisings to satisfy its working capital requirements.

Summary of 4DMedical's funding facility announcement

4DMedical Limited (ASX: $4DX) has secured an At-the-Market (ATM) funding facility with Alpha Investment Partners (AIP) to support the commercialization of XV Technology® in the US and Australia. The ATM facility will provide the company with up to $30m of equity capital over the next 3 years, in addition to its strong cash balance of $41.2m as of 31 March 2024. This versatile, cost-effective, low-impact funding mechanism will augment 4DMedical's capital management program and support its progress to profitability as operational milestones are delivered, while ensuring shareholder dilution is minimized. The company will retain full control over all major aspects of the placement process, including sole discretion on whether to utilize the ATM, the number of shares to be issued, and the floor price. The ATM facility does not preclude 4DMedical from raising capital via any other means should strategic opportunities present themselves. With the funding facility in place, 4DMedical aims to continue its rapid, scalable growth and capitalize on significant upside opportunities in the short and medium term.